1-3 of 3
Todd R Lenvik
Close
Sort by
Journal Articles

PD-1 Is Expressed at Low Levels on All Peripheral Blood Natural Killer Cells but Is a Significant Suppressor of NK Function Against PD-1 Ligand Expressing Tumor Targets

Zachary Davis, PhD BS, Martin Felices, PhD, Todd R Lenvik, Sujan Badal, Peter Hinderlie, Bruce R. Blazar, MD, Daniel A. Vallera, PhD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 621.
https://doi.org/10.1182/blood-2019-127261
Published: 2019
Journal Articles

Second-Generation Camelid Trike Induces Improved NK Cell Mediated Targeting of AML in Pre-Clinical Models

Martin Felices, PhD, Craig E. Eckfeldt, MD PhD, Todd R Lenvik, Behiye Kodal, Alexander J. Lenvik, Laura Bendzick, Caitlin Ryan, Melissa A. Geller, Sarah Cooley, MD, Daniel J. Weisdorf, MD, Daniel A. Vallera, PhD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4465.
https://doi.org/10.1182/blood.V130.Suppl_1.4465.4465
Published: 2017
Journal Articles

Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9

Michelle K. Gleason, Todd R. Lenvik, Valarie McCullar, Martin Felices, M. Shea O'Brien, Sarah A. Cooley, Michael R. Verneris, Frank Cichocki, Carol J. Holman, Angela Panoskaltsis-Mortari, Toshiro Niki, Mitsuomi Hirashima, Bruce R. Blazar, Jeffrey S. Miller
Journal: Blood
Blood (2012) 119 (13): 3064–3072.
https://doi.org/10.1182/blood-2011-06-360321
Published: 2012
Includes: Supplemental data